Highly Accessed Open Badges Meeting report

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Alan Tyndall1*, Ulrich A Walker1, Andrew Cope2, Francesco Dazzi3, Cosimo De Bari2, Willem Fibbe4, Serena Guiducci5, Simon Jones3, Christian Jorgensen6, Katarina Le Blanc7, Frank Luyten8, Dennis McGonagle9, Ivan Martin1, Chiara Bocelli-Tyndall1, Giuseppina Pennesi10, Vito Pistoia11, Constantino Pitzalis2, Antonio Uccelli12, Nico Wulffraat13 and Marc Feldmann2

Author Affiliations

1 Rheumatology, University Hospital Basel, Felix Platter Spital, Burgfelderstrasse 101, Basel, CH-4012, Switzerland

2 Medicine, DIIID, Rheumatology, King's College London, Strand, London, WC2R 2LS, UK

3 Stem Cell Biology, Kennedy Institute of Rheumatology Division, ARC Building, 1 Aspenlea Road, London, W6 8LH, UK

4 Immunohematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef 2, Building 1, E3-Q, Leiden, 2300 RC, The Netherlands

5 Internal Medicine, Division of Rheumatology, University of Florence, Viale Morgagni, 85, Florence, I-50134, Italy

6 Service d'Immuno-Rhumatologie, Lapeyronie University Hospital, 371, av. du Doyen Gaston Giraud, Montpellier, F – 34295, France

7 Division of Clinical Immunology, Karolinska Institute, CMB, Box 285, Stockholm, SE-171 77, Sweden

8 Rheumatology Section, Leuven University Medical Centre, Herestraat 49, bus 813, Leuven, B – 3000, Belgium

9 Molecular Medicine Unit, Rheumatology, University of Leeds, Woodhouse Lane, Leeds, LS2 9JT, UK

10 Neuroimmunologia, University of Genova, Via L.B. Alberti, 4, Genova, I-16132, Italy

11 Laboratorio Scientifico di Oncologia, G. Gaslini Scientific Institute, Largo Gerolamo Gaslini, 5, Genova, I-16147, Italy

12 Department di Neuroscienze, University of Genova, Via L.B. Alberti, 4, Genova, I-16132, Italy

13 Department of Pediatric Immunolgy, University Medical Center Utrecht, Room KC03.063.0, Utrecht, NL-3508 AB, The Netherlands

For all author emails, please log on.

Arthritis Research & Therapy 2007, 9:301  doi:10.1186/ar2103

Published: 29 January 2007


Multipotent mesenchymal stromal cells isolated from bone marrow and other sites are currently being studied to determine their potential role in the pathogenesis and/or management of autoimmune diseases. In vitro studies have shown that they exhibit a dose-dependent antiproliferative effect on T and B lymphocytes, dendritic cells, natural killer cells and various B cell tumour lines – an effect that is both cell contact and soluble factor dependent. Animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response, as have a limited number of patients suffering from acute graft versus host disease. This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts.